Danaher Corporation share price logo

Danaher Corporation

NYSE: DHR

Large Cap

$174.57

-0.35

(-0.20%)

Live

as on

Danaher Corporation Stock Performance

as on May 8, 2026 at 3:07 am IST

  • Day's Low

    Day's High

    $174.14
    $177.01
    downward going graph

    0.25%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $172.06
    $242.80
    downward going graph

    1.44%

    Downside

    39.08%

    Upside

    downward going graph

Danaher Corporation share price movements today

Previous Close
$174.92
Open
$175.85
Volume
968.2K
Day's Low - High
$174.14 - $177.01
52 Week Low - High
$172.06 - $242.80

Danaher Corporation Historical Returns

1 Month Return
-8.42 %
3 Month Return
-19.25 %
1 Year Return
-9.41 %
3 Year Return
-27.85 %
5 Year Return
-32.33 %

Danaher Corporation Stock Fundamentals & Key Indicators

Check Danaher Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$123.8B

EPS (TTM)

8.4355

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.10%

PE Ratio (TTM)

33.9

Industry PE ratio

25.55818181818182

PEG Ratio

1.1138

EBITDA

7.9B

Revenue (TTM)

24.8B

Profit Margin

14.89%

Return On Equity TTM

7.08%

Danaher Corporation Stock Valuation

Track how Danaher Corporation P/E has moved over time to understand its valuation trends.

Danaher Corporation in the last 5 years

  • Overview

  • Trends

Lowest (23.88x)

December 31, 2022

Industry (25.56x)

May 7, 2026

Today (33.90x)

May 7, 2026

Highest (35.57x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.90x

Danaher Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Danaher Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Danaher Corporation image
Danaher Corporation
BUY$123.8B-32.33%33.914.89%
IDEXX Laboratories Inc image
IDEXX Laboratories Inc
BUY$45.7B6.43%42.6824.63%
Waters Corporation image
Waters Corporation
HOLD$34.3B11.09%44.5311.93%
Thermo Fisher Scientific Inc image
Thermo Fisher Scientific Inc
BUY$175.8B0.96%25.9715.15%

Stock Returns calculator for Danaher Corporation Stock including INR - Dollar returns

The Danaher Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Danaher Corporation investment value today

Current value as on today

₹1,00,566

Returns

₹566

(+0.57%)

Returns from Danaher Corporation Stock

-₹9,591 (-9.59%)

Dollar Impact

₹10,157 (+10.16%)

Analyst Recommendation on Danaher Corporation Stock

Based on 30 analysts

BUY

73.33%

Buy

23.33%

Hold

3.33%

Sell

Based on 30 analysts, 73.33% of analysts recommend a 'BUY' rating for Danaher Corporation. Average target price of $250.14

Danaher Corporation Share Price Target

Get share price movements and forecasts by analysts on Danaher Corporation.

What analysts predicted

30.21%UPSIDE

Target Price

$250.14

Current Price

$174.57

Analyzed by

30 Analysts

Target

$250.14

Danaher Corporation target price $250.14, a slight upside of 30.21% compared to current price of $174.57. According to 30 analysts rating.

Indian Investors' Interest in Danaher Corporation Stock

Investment in Danaher Corporation Shares on INDmoney has grown by 127.77% in the last 30 days, indicating increased investment activity.

Time period: to

Change:127.77% versus previous 30 day period

Search interest for Danaher Corporation Stock has increased by 95% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:95% versus previous 30 day period

Danaher Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
6,405
5,796
5,743
5,798
6,538
5,741
5,936
6,053
6,838
5,951
Gross Profit
3,779
3,487
3,428
3,401
3,890
3,526
3,955
3,523
3,966
3,591
Operating Income
1,414
1,312
1,168
958
1,746
1,289
1,192
1,154
1,502
1,344
EBITDA
1,810
1,922
1,728
1,655
1,971
1,792
1,337
1,765
2,051
1,537
Interest Expense
85
65
65
87
61
72
71
67
55
63
Depreciation
493
586
580
591
595
591
611
622
623
627
Income Before Tax
1,232
1,271
1,083
977
1,315
1,129
655
1,076
1,373
1,235
Income Tax Expense
111
183
176
159
229
175
100
168
176
206
Net Income
1,079
1,088
907
818
1,086
954
555
908
1,197
1,029
Net Profit Margin
16.85%
18.77%
15.79%
14.11%
16.61%
16.62%
9.35%
15.00%
17.51%
17.29%

Danaher Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16,882
18,329
17,048
17,911
22,284
29,453
26,643
23,890
23,875
24,568
Gross Profit
9,383
10,230
9,505
9,983
12,475
17,952
16,188
14,034
14,206
14,970
Operating Income
2,987
3,149
3,070
3,362
4,312
8,050
7,536
5,202
5,184
5,137
EBITDA
3,923
4,339
4,276
4,603
6,543
10,007
9,485
5,202
7,276
6,945
Interest Expense
184
162
136
108
273
241
207
286
278
265
Depreciation
-
1,238
1,307
1,189
1,775
2,168
2,222
2,238
2,352
2,447
Income Before Tax
2,611
2,938
2,961
3,305
4,495
7,598
7,146
5,044
4,646
4,233
Income Tax Expense
457
469
555
873
849
1,251
818
301
747
619
Net Income
2,553
2,492
2,650
2,557
3,646
6,433
7,209
4,743
3,899
3,614
Net Profit Margin
15.13%
13.60%
15.55%
14.28%
16.36%
21.84%
27.06%
19.85%
16.33%
14.71%

Danaher Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
1,088
907
818
1,086
954
555
908
1,197
1,029
Operating Cash Flow
1,739
1,417
1,513
2,019
1,299
1,338
1,662
2,117
1,322
Investing Cash Flow
-321
-360
-606
-694
-242
-258
-312
-384
-249
Financing Cash Flow
-133
-5,715
-845
-1,692
-1,255
-247
-2,724
1,265
46
Change in Cash
1,167
-4,657
253
-549
-85
964
-782
3,097
1,086

Danaher Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,469
2,650
2,432
3,646
6,347
7,209
4,221
3,899
3,614
Operating Cash Flow
3,477
4,022
3,951
6,208
8,358
8,519
7,164
6,688
6,416
Investing Cash Flow
-843
-2,949
-1,238
-21,239
-12,987
-2,234
-7,081
-1,981
-1,196
Financing Cash Flow
-3,098
-797
16,365
1,006
1,295
-2,570
-273
-8,385
-2,961
Change in Cash
-333
157
19,124
-13,877
-3,449
3,409
-131
-3,786
2,537

Mutual Funds that own Danaher Corporation Stock

Check out the Mutual Funds with significant holdings in Danaher Corporation.

Global Institutional Holdings in Danaher Corporation

Funds
Holdings
Vanguard Group Inc
8.62%
JPMorgan Chase & Co
3.05%
State Street Corp
3.84%
Capital Research & Mgmt Co - Division 3
2.37%
Capital Research & Mgmt Co - Division 3
2.58%
See all

Danaher Corporation News & Key Events

  • img

    Today's Timeline - 21 April

    Tue, 09:57 PM

    -

    Danaher reports Q1 2026 adjusted EPS of $2.06, beating estimates, but revenue of $5.95 billion misses expectations.

Insights on Danaher Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, IDEXX Laboratories, Inc. has given 19.0% return, outperforming this stock by 28.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, IDEXX Laboratories, Inc. has given 18.6% return, outperforming this stock by 46.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Danaher Corp. has seen a decline in its net profit for the last two quarters. The net profit decreased from $1.19 billion to $1.02 billion, resulting in an average decrease of 14.0% per quarter.

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Danaher Corp. has experienced a decline in revenue over the last two quarters. The revenue decreased from $6.83 billion to $5.95 billion, reflecting an average decrease of 13.0% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DHR stock has moved down by -8.4%

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
OrganisationDanaher Corporation
Headquarters2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701
IndustryDiagnostics & Research
CEOMr. Rainer M. Blair
E-voting on sharesClick here to vote

Key Management of Danaher Corporation

Name

Title

Mr. Mitchell P. Rales

Co-Founder & Director

Mr. Christopher Paul Riley

Executive VP of Biotechnology Group & CEO of Cytiva

Ms. Julie Sawyer Montgomery

Executive Vice President of Diagnostics Platform

Mr. Matthew E. Gugino C.F.A., CPA

Executive VP & CFO

Mr. Steven M. Rales

Co-Founder & Chairman

Mr. Rainer M. Blair

President, CEO & Director

Dr. Jose-Carlos Gutierrez-Ramos Ph.D.

Senior VP & Chief Science Officer

Mr. Matthew R. McGrew

Executive Vice President

Mr. Christopher M. Bouda

VP & Chief Accounting Officer

Dr. Martin Stumpe Ph.D.

Chief Technology & AI Officer

FAQs

What is Danaher Corporation share price today?

Danaher Corporation share price today is $174.57 as on . Danaher Corporation share today touched a day high of $177.01 and a low of $174.14.

What is the 52 week high and 52 week low for Danaher Corporation share?

Danaher Corporation share touched a 52 week high of $242.8 on and a 52 week low of $172.06 on . Danaher Corporation stock price today i.e. is trending at $174.57,which is 28.10% down from its 52 week high and 1.46% up from its 52 week low.

What is Danaher Corporation's market capitalisation today?

Danaher Corporation market capitalisation is $0.12T as on .

How to invest in Danaher Corporation Stock (DHR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Danaher Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Danaher Corporation Shares that will get you 0.0086 shares as per Danaher Corporation share price of $174.57 per share as on May 7, 2026 at 9:37 pm IST.

What is the minimum amount required to buy Danaher Corporation Stock (DHR) from India?

Indian investors can start investing in Danaher Corporation (DHR) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Danaher Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Danaher Corporation share’s latest price of $174.57 as on May 7, 2026 at 9:37 pm IST, you will get 0.0573 shares of Danaher Corporation. Learn more about fractional shares .

What are the returns that Danaher Corporation has given to Indian investors in the last 5 years?

Danaher Corporation stock has given -32.33% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?